Rouchy R C, Moreau-Gaudry A, Chipon E, Aubry S, Pazart L, Lapuyade B, Durand M, Hajjam M, Pottier S, Renard B, Logier R, Orry X, Cherifi A, Quehen E, Kervio G, Favelle O, Patat F, De Kerviler E, Hughes C, Medici M, Ghelfi J, Mounier A, Bricault I
Clinique Universitaire de Radiologie et Imagerie Médicale, Centre Hospitalier Universitaire (CHU) de Grenoble-Alpes, F-38000, Grenoble, France.
Institut national de la santé et de la recherche médicale (Inserm) Centre d'Investigation Clinique (CIC) 1406, University Grenoble-Alpes, F-38000, Grenoble, France.
Trials. 2017 Jul 6;18(1):306. doi: 10.1186/s13063-017-2049-6.
Interventional radiology includes a range of minimally invasive image-guided diagnostic and therapeutic procedures that have become routine clinical practice. Each procedure involves a percutaneous needle insertion, often guided using computed tomography (CT) because of its availability and usability. However, procedures remain complicated, in particular when an obstacle must be avoided, meaning that an oblique trajectory is required. Navigation systems track the operator's instruments, meaning the position and progression of the instruments are visualised in real time on the patient's images. A novel electromagnetic navigation system for CT-guided interventional procedures (IMACTIS-CT®) has been developed, and a previous clinical trial demonstrated improved needle placement accuracy in navigation-assisted procedures. In the present trial, we are evaluating the clinical benefit of the navigation system during the needle insertion step of CT-guided procedures in the thoraco-abdominal region.
METHODS/DESIGN: This study is designed as an open, multicentre, prospective, randomised, controlled interventional clinical trial and is structured as a standard two-arm, parallel-design, individually randomised trial. A maximum of 500 patients will be enrolled. In the experimental arm (navigation system), the procedures are carried out using navigation assistance, and in the active comparator arm (CT), the procedures are carried out with conventional CT guidance. The randomisation is stratified by centre and by the expected difficulty of the procedure. The primary outcome of the trial is a combined criterion to assess the safety (number of serious adverse events), efficacy (number of targets reached) and performance (number of control scans acquired) of navigation-assisted, CT-guided procedures as evaluated by a blinded radiologist and confirmed by an expert committee in case of discordance. The secondary outcomes are (1) the duration of the procedure, (2) the satisfaction of the operator and (3) the irradiation dose delivered, with (4) subgroup analysis according to the expected difficulty of the procedure, as well as an evaluation of (5) the usability of the device.
This trial addresses the lack of published high-level evidence studies in which navigation-assisted CT-guided interventional procedures are evaluated. This trial is important because it addresses the problems associated with conventional CT guidance and is particularly relevant because the number of interventional radiology procedures carried out in routine clinical practice is increasing.
ClinicalTrials.gov identifier: NCT01896219 . Registered on 5 July 2013.
介入放射学包括一系列微创的影像引导诊断和治疗程序,这些程序已成为常规临床实践。每个程序都涉及经皮穿刺针插入,由于计算机断层扫描(CT)的可用性和易用性,通常使用CT引导。然而,这些程序仍然很复杂,特别是当必须避开障碍物时,这意味着需要采用斜向轨迹。导航系统可跟踪操作者的器械,即器械的位置和行进情况会在患者图像上实时显示。一种用于CT引导介入程序的新型电磁导航系统(IMACTIS-CT®)已被开发出来,先前的一项临床试验表明,在导航辅助程序中针的放置准确性有所提高。在本试验中,我们正在评估该导航系统在胸腹部区域CT引导程序的针插入步骤中的临床益处。
方法/设计:本研究设计为一项开放、多中心、前瞻性、随机、对照介入临床试验,采用标准的双臂平行设计、个体随机试验结构。最多将招募500名患者。在试验组(导航系统组),程序在导航辅助下进行;在活性对照臂(CT组),程序在传统CT引导下进行。随机分组按中心和程序的预期难度分层。试验的主要结局是一个综合标准,用于评估由一名盲态放射科医生评估并在意见不一致时由专家委员会确认的导航辅助CT引导程序的安全性(严重不良事件数量)、有效性(到达靶点数量)和性能(获取的对照扫描数量)。次要结局包括:(1)程序持续时间;(2)操作者满意度;(3)所给予的辐射剂量;(4)根据程序的预期难度进行亚组分析,以及对(5)设备易用性的评估。
本试验解决了缺乏已发表的对导航辅助CT引导介入程序进行评估的高水平证据研究的问题。本试验很重要,因为它解决了与传统CT引导相关的问题,而且特别相关的是,在常规临床实践中进行的介入放射学程序数量正在增加。
ClinicalTrials.gov标识符:NCT01896219。于2013年7月5日注册。